Medtronic LR-ACT Instrucciones De Uso página 92

ACTCART_Ref.FM 6/1/04 9:51 am
UC199600212b ML
7 x 9 inches (177.8 x 228.6 mm)
REFERENCES
REFERENCES
RÉFÉRENCES / LITERATUR / REFERENCIAS / BIBLIOGRAFIE / BIBLIOGRAFIA /
KIRJALLISUUSVIITTEET / REFERENSER / ΒΙΒΛΙΟΓΡΑΦΙΑ / REFERENCER / REFERÊNCIAS
1. Bull BS, Korpman RA, Huse WM, Briggs BD. Heparin therapy during extra-corporeal circulation. I. Problems inherent
in existing heparin protocol. J Thorac Cardiovasc Surg. 1975;69:674-684.
2. Bull BS, Huse MH, Brauer FS, Korpman RA. Heparin therapy during extra-corporeal circulation. II. The use of a dose-
response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685-689.
3. Dauchot PJ, Berzina-Moettus L, Rabinovitch A, Ankeney JL. Activated coagulation and activated partial
thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
Anesth Analg. 1983;62:710-719.
4. Effeney DJ, Goldstone J, Chin D, Krupski WC, Ellis RJ. Interoperative anticoagulation in cardiovascular surgery.
Surgery. 1981;90:1068-1074.
5. Esposito RA, Culliford AT, Colvin SB, Thomas SJ, Lackner H, Spencer FC. The role of the activated clotting time in
heparin administration and neutralization for cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;85:174-185.
6. Hattersley PG. Activated coagulation time of whole blood. JAMA. 1966;196:436.
7. Hattersley PG, Mitsuoka JC, King JH. The use of the activated coagulation time (ACT) as a monitor of heparin therapy.
In: Lundblad RL, Brown WV, Mann KG, Roberts HR, eds. Chemistry and Biology of Heparin. North Holland: Elsevier;
1981;659.
8. Henry JB. Clinical Diagnosis and Management by Laboratory Methods. Vol 1. 16
Company; 1979.
9. Moorehead MT, Westengard JC, Bull BS. Platelet involvement in the activated coagulation time of heparinized blood.
Anesth Analg. 1984;63:394-398.
10. Niinikoski J, Laato M, Laaksonen V, Jalonen J, Ingerg MV. Use of activated clotting time to monitor anticoagulation
during cardiac surgery. Scand J Thor Cardiovasc Surg. 1984;18:57-61.
11. Reno WJ, Rotman M, Grumbine FC, Dennis LH, Mohler ER. Evaluation of the BART test (a modification of the whole-
blood activated recalcification time test) as a means of monitoring heparin therapy. Am J Clin Path. 1974;61:78-84.
12. Roth JA, Cukingnan RA, Scott CR. Use of activated coagulation time to monitor heparin during cardiac surgery. Ann
Thorac Surg. 1978;28:69-72.
13. Sirridge MS. Laboratory Evaluation of Hemostasis. 2
14. Wilhelmsson S, Lins L-E. Whole-blood activated coagulation time for evaluation of heparin activity during
hemodialysis: A comparison of administration by single-dose and by infusion. Clin Nephr. 1983;19:82-86.
15. Young DS, Pastaner LC, Gibberman V. Effects of drugs on clinical laboratory tests. Clin Chem. 1975;21:1D.
90
231036-00
th
ed. Philadelphia, PA: WB Saunders
nd
ed. Philadelphia, PA: Lea and Febiger; 1974.
Medtronic Confidential
CS009